Floatz logo

Budesonide

HER2 Positive Breast Carcinoma

Puma Biotechnology, Inc.Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

176 Active assets in the HER2 Positive Breast Carcinoma cohort.

Asset / SponsorPhaseRating
TRASTUZUMAB
SWOG Cancer Research Network
Phase 4BB
Pertuzumab
SWOG Cancer Research Network
Phase 4BB
Ribociclib
Danish Breast Cancer Cooperative Group
Phase 3BB
Docetaxel
Ohio State University Comprehensive Cancer Center
Phase 3BB
Capecitabine
MedSIR
Phase 4BB

View all 50 →

Same molecule, other indications

Budesonide is also rated in:

asthmaDormant
BBB
Indicative · Phase 4
79 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
B
Indicative · Phase 4
63 / 100
View asset →
primary biliary cholangitisDormant
B
Indicative · Phase 3
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →